President Donald Trump has signed an executive order directing the FDA to reduce regulatory hurdles that stand in the way of ...

In its announcement, OpenAI called GPT-Rosalind a "frontier reasoning model built to support research across biology, drug ...

When Kailera revealed its plans for an IPO last month, there was a feeling that it could be huge – and that expectation has ...

The FDA may have approved Eli Lilly's oral weight-loss drug Foundayo in record time, but it still needs to see more safety ...

In September last year, we reported Servier had advanced its emerging neurology pipeline into the clinical trials stage by ...

In our final video from the LSX World Congress in Lisbon, Portugal, web editor Nicole Raleigh spoke with Paulo Neves, CMO of ...

The revitalisation of GSK's Blenrep has continued with the news that the NHS in England can use the BCMA-targeting multiple ...

These documents are written in dense, lawyer-like language that requires individual interpretation from each function; ...

The months-long absence of permanent leadership at the CDC could soon be at an end, after President Trump nominated former ...

The ABPI, in the 3 rd March blog by Pinchas Kahtan, highlighted “early signs of a modest recovery in clinical trial ...

Medicines are uniquely vulnerable to disruptions caused by conflict, as unlike many other goods, they are tightly regulated ...

The UK has made progress in its efforts to slash set-up times for clinical trials, one of the factors blamed for a decline in ...